EP3641721A1 - Emulsionen mit (poly)hydroxycarbonsäuren, mono- oder distearaten und stärke - Google Patents
Emulsionen mit (poly)hydroxycarbonsäuren, mono- oder distearaten und stärkeInfo
- Publication number
- EP3641721A1 EP3641721A1 EP18727749.6A EP18727749A EP3641721A1 EP 3641721 A1 EP3641721 A1 EP 3641721A1 EP 18727749 A EP18727749 A EP 18727749A EP 3641721 A1 EP3641721 A1 EP 3641721A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- acids
- hydroxycarboxylic
- acid
- groups
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- the present invention relates to cosmetic preparations containing one or more ⁇ -hydroxycarboxylic acids and / or one or more ⁇ -hydroxycarboxylic acids and / or one or more polyhydroxy acids, one or more distearates and starch.
- the skin is exposed to stress from numerous external and internal factors. Extrinsic factors include ultraviolet radiation (eg, sunshine), pollution, wind, heat, low humidity, aggressive surfactants, abrasives, and the like.
- Intrinsic factors include chronological age and other biochemical changes within the skin. Whether externally or internally, these factors result in visible signs of skin aging and environmental damage, such as the appearance of wrinkles and other forms of roughness (including enlarged pores, scales). and other histological changes associated with skin aging or damage. Skin folds remind many people of the disappearance of youth.
- the aim of skin care is also to compensate for the daily loss of fat and water loss of the skin. This is especially important when the natural regeneration capacity is insufficient.
- skin care products to protect against environmental influences, especially from the sun and wind, and delay the aging of the skin.
- Exogenous factors such as UV light and chemical noxae can be cumulatively effective and e.g. accelerate or supplement endogenous aging processes.
- exogenous factors occur, e.g. on the following structural damage and dysfunction in the skin that go beyond the extent and quality of the damage caused by chronological aging: d) visible vascular dilations (telangiectasias, cuperosis);
- the present invention relates in particular to products for the care of naturally aged skin, as well as for the treatment of the consequential damage of photoageing, in particular the phenomena listed under a) to g).
- Such preparations are particularly suitable for the treatment and / or prevention of skin damage caused by UV light, as well as skin aging effects or else for the treatment of pigmentation disorders and / or skin lightening. It is also possible to use for the treatment of acne and desquamation
- a process for the production of O / W emulsions is characterized in that mixtures of
- an oil phase are dissolved or dispersed, and oil and water phase, optionally emulsified with heating and stirring with each other.
- ⁇ -hydroxycarboxylic acid or acids are advantageously selected from the compounds of the general formula
- X denotes an aliphatic CH 2 group, a cycloaliphatic CH group, an aromatic CH group or a CH (OH) group
- ⁇ -hydroxycarboxylic acid or the ⁇ -hydroxycarboxylic acids or the ⁇ -hydroxycarboxylic acid or the ⁇ -hydroxycarboxylic acids may optionally be present in the form of their physiologically acceptable salts and / or ethyl esters and / or methyl esters.
- Preferred ⁇ -hydroxycarboxylic acids are glycolic acid, lactic acid and citric acid.
- Preferred ⁇ -hydroxycarboxylic acid is salicylic acid, and the preferred polyhydroxy acid is gluconolactone.
- Preferred distearate is PEG-150 distearate.
- Preferred monostearates are glyceryl stearate and PEG ⁇ IO stearate.
- the cosmetic or dermatological preparations according to the invention may be composed as usual and used for the treatment, care and cleansing of the skin and / or the hair and as a make-up product in decorative cosmetics. They preferably contain 5 to 10 wt., Based on the total weight of the preparations, of one or more a-hydroxycarboxylic acids and or one or more ß-hydroxycarboxylic acids.
- the cosmetic or dermatological preparations according to the invention preferably contain 0.001% by weight to 10% by weight, preferably 0.05% by weight to 5% by weight, in particular 0.1-2.0% by weight, based on the total weight of the preparations, on one or more disintrates having a melting range in the temperature range of 53-64 ° C.
- the cosmetic or dermatological preparations according to the invention preferably contain 0.001% by weight to 10% by weight, preferably 0.05% by weight to 5% by weight, in particular 0.1-2.0% by weight, based on the total weight of the preparations, on one or more monostearates, which have a melting range in the temperature range of 40-57 ° C.
- Emulsions according to the invention for the purposes of the present invention are advantageous and contain e.g. Fats, oils, waxes and / or other fatty substances, as well as water and one or more emulsifiers, as they are commonly used for such a type of formulation.
- Medicinal topical compositions according to the present invention usually contain one or more drugs in effective concentration.
- the cosmetic and / or dermatological formulations according to the invention may be composed as usual and used for the treatment of the skin and / or the hair in the sense of a dermatological treatment or a treatment in the sense of nourishing cosmetics. But they can also be used in make-up products in decorative cosmetics or in the cosmetic and dermatological cleaning products.
- the solvents used can be: water or aqueous solutions, furthermore oils, such as triglycerides of capric or caprylic acid, but preferably castor oil, fats, waxes and other natural and synthetic fatty substances, preferably Esters of fatty acids with low C-number alcohols, eg with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low C number or with fatty acids, but also alcohols, diols or polyols of low C number, and their ethers, preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products.
- oils such as triglycerides of capric or caprylic acid, but
- mixtures of the abovementioned solvents are used, as may be an advantageous further constituent of alcohol in the case of alcoholic solvents.
- the active compounds according to the invention can also be used with particular advantage in microemulsions, for example as described in German Offenlegungsschrift DE-195 9 079.
- the oil phase of the preparations according to the invention is advantageously selected from the group of esters of saturated and / or unsaturated, branched and / or unbranched alcohols.
- kancarbonchuren a chain length of 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or unbranched alcohols of a chain length of 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and or unbranched alcohols of a chain length of 3 to 30 carbon atoms.
- ester oils can then advantageously be selected from the group of isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2 Hexyldecyl stearate, 2-octyl dodecyl palmitate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate and synthetic, semi-synthetic and natural mixtures of such esters, for example jojoba oil.
- the oil phase can be advantageously selected from the group of branched and unbranched hydrocarbons and waxes, the silicone oils, the dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and the fatty acid triglycerides, namely the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids of a chain length of 8 to 24, in particular 12 to 18 carbon atoms.
- the fatty acid triglycerides can be advantageously selected from the group of synthetic, semi-synthetic and natural oils, e.g. Olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil, and the like.
- the oil phase is advantageously selected from the group 2-ethylhexyl isostearate, octyldodecanol, isotridecyl isononanoate, isoeicosane, 2-ethylhexyl cocoate, C12-15-alkyl benzoate, caprylic-capric triglyceride, dicaprylyl ether.
- mixtures of C12-15-alkyl benzoate and 2-ethylhexyl isostearate mixtures of C12-15-alkyl benzoate and Isotridecylisononanoat and mixtures of C12-15-alkyl benzoate, 2-Ethylhexylisostearat and Isotridecylisononanoat.
- the oil phase may further comprise a content of cyclic or linear silicone oils or consist entirely of such oils, although it is preferred to use an additional content of other Olphasenkomponenten except the silicone oil or silicone oils.
- cyclomethicone octamethylcyclotetrasiloxane
- silicone oils are also advantageous for the purposes of the present invention, for example hexamethylcyclotrisiloxane, polydimethylsiloxane, poly (methylphenylsiloxane).
- mixtures of cyclomethicone and isotridecyl isononanoate, cyclomethicone and 2-ethylhexyl isostearate are particularly advantageous.
- the content of the oil phase is between 1 and 50 wt .-%, based on the total weight of the preparations, preferably 2.5 to 30 wt .-%, particularly preferably 5 to 15 wt .-%.
- the cosmetic and / or dermatological formulations according to the invention are applied to the skin in a sufficient amount in the manner customary for cosmetics and dermatological agents.
- Ethylhexyltriazone 1 500 Bis-ethylhexyloxyphenol Methoxylphenyl Trazine 3,000
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102017210389.2A DE102017210389A1 (de) | 2017-06-21 | 2017-06-21 | Kosmetische Zubereitungen mit einem Gehalt an einer oder mehreren alpha-Hydroxycarbonsäuren und/oder einer oder mehreren beta-Hydroxycarbonsäuren und/oder einer oder mehreren Polyhydroxysäuren, einem oder mehreren Distearaten und Stärke |
PCT/EP2018/063334 WO2018233962A1 (de) | 2017-06-21 | 2018-05-22 | Emulsionen mit (poly)hydroxycarbonsäuren, mono- oder distearaten und stärke |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3641721A1 true EP3641721A1 (de) | 2020-04-29 |
Family
ID=62386423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18727749.6A Withdrawn EP3641721A1 (de) | 2017-06-21 | 2018-05-22 | Emulsionen mit (poly)hydroxycarbonsäuren, mono- oder distearaten und stärke |
Country Status (4)
Country | Link |
---|---|
US (1) | US20200113797A1 (de) |
EP (1) | EP3641721A1 (de) |
DE (1) | DE102017210389A1 (de) |
WO (1) | WO2018233962A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230136806A1 (en) * | 2021-10-29 | 2023-05-04 | L'oreal | Oxidizer and acid based system and regimen for enhancing skin appearance |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1959079A1 (de) | 1969-11-25 | 1971-07-08 | Stavebni Strojirenstvi A Lehka | Foerdervorrichtung fuer rohe Ziegeleierzeugnisse |
US5961999A (en) * | 1995-06-08 | 1999-10-05 | Wella Aktiengesellschaft | Method of skin care using a skin care preparation containing a betaine ester and an α-hydroxy acid |
US6440432B1 (en) * | 1999-03-18 | 2002-08-27 | Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. | Skin cosmetic compositions containing dextran or maltodextrin and a weak carboxylic acid |
DE19919481A1 (de) * | 1999-04-29 | 2000-11-02 | Beiersdorf Ag | Stabile, gegen unreine Haut und gegen Akne wirksame Wirkstoffkombinationen mit einem Gehalt an grenzflächenaktiven Glucosederivaten und Hydroxycarbonsäuren |
DE10213957A1 (de) * | 2002-03-28 | 2003-10-09 | Beiersdorf Ag | Vernetzte kosmetische oder pharmazeutische phospholipidhaltige Gele und Emulsionen auf der Basis von ethylenoxidhaltigen oder propylenoxidhaltigen Emulgatoren |
EP1948236B1 (de) * | 2005-09-27 | 2021-03-03 | Special Water Patents B.V. | Methoden und zusammensetzungen zur behandlung der haut |
-
2017
- 2017-06-21 DE DE102017210389.2A patent/DE102017210389A1/de not_active Withdrawn
-
2018
- 2018-05-22 US US16/623,466 patent/US20200113797A1/en not_active Abandoned
- 2018-05-22 EP EP18727749.6A patent/EP3641721A1/de not_active Withdrawn
- 2018-05-22 WO PCT/EP2018/063334 patent/WO2018233962A1/de unknown
Also Published As
Publication number | Publication date |
---|---|
WO2018233962A1 (de) | 2018-12-27 |
DE102017210389A1 (de) | 2018-12-27 |
US20200113797A1 (en) | 2020-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0945126B1 (de) | Kosmetische oder dermatologische Zusammensetzung bestehend aus Carnitin und/oder einem Acylcarnitin, und mindestens einem Antioxidans | |
DE10301632A1 (de) | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Kreatin, Kreatinin und/oder seinen Derivaten in Kombination mit Sojabohnenkeimextrakten | |
DE10342212A1 (de) | Verwendung von Licocalchon A oder eines Licocalchon A enthaltenden Extraktes aus Radix Glycyrrhizae inflatae gegen Hautalterung | |
WO2003011242A1 (de) | Kosmetische oder dermatologische zubereitungen mit einer kombination von kreatinin und/oder kreatininderivaten mit kreatin und/oder seinen derivaten | |
DE4444237C2 (de) | Verwendung von Wirkstoffkombinationen zur Bekämpfung durch Propionibacterium acnes hervorgerufener unreiner Haut sowie leichter Formen der Akne | |
WO1999037273A2 (de) | Kosmetische und dermatologische zubereitungen, enthaltend erhöhte elektrolytkonzentrationen | |
DE19802204A1 (de) | Kosmetische oder pharmazeutische Zubereitungen mit vermindertem Klebrigkeitsgefühl, enthaltend Glycerinester von -Hydroxycarbonsäuren und gesättigten Fettsäuren | |
DE10039063A1 (de) | Kosmetische und dermatologische Zubereitung mit einem Gehalt an Cyclodextrinen zur Beseitigung von Sebum | |
DE102004012135A1 (de) | Zubereitung gegen gerötete Haut | |
EP1084701A1 (de) | O/W-Emulsion mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerina | |
WO2018233962A1 (de) | Emulsionen mit (poly)hydroxycarbonsäuren, mono- oder distearaten und stärke | |
WO2003011241A1 (de) | Verwendung von kreatinin und/oder kreatininderivaten in kosmetischen oder dermatologischen zubereitungen | |
EP1000603B1 (de) | Verwendung von oberflächenaktiven Citronensäureestern zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und oberflächenaktiven Substanzen sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen | |
EP1397119A2 (de) | Verwendung von natriumpolystyrolsulfonat zur hautstraffung | |
DE102004013633A1 (de) | Tapioka in kosmetischen Zubereitungen | |
EP1175897A2 (de) | Kosmetische oder dermatologische Formulierung zur Pflege und Kühlung der Haut nach einem Sonnenbad | |
WO2002076409A2 (de) | Kosmetische und dermatologische zubereitungen mit einem gehalt an isoflavonen | |
DE102004013607A1 (de) | Lipidkombination gegen aschenfarbene Haut | |
WO2005030157A1 (de) | Kosmetische oder dermatologische zubereitungen mit einem gehalt an isoflavonen und licochalcon a | |
WO2016078853A1 (de) | Zubereitungen mit einem gehalt an ascorbinsäure, ubidecarenon und einem emulgatorgemisch | |
DE10121069A1 (de) | Verwendung von Tetrahydrocurcuminoiden oder deren Derivaten als Wirkstoffe zur Herstellung von kosmetischen und dermatologischen Zubereitungen zum Schutz und zur Behandlung der trockenen bzw. alterstrockenen Haut | |
WO2002076410A2 (de) | Kosmetische und dermatologische zubereitungen mit einem gehalt an hopfen- bzw. hopfen-malz-extrakt | |
DE19845324A1 (de) | Verwendung von Nitrilotriessigsäure zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und Nitrilessigsäure sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen | |
WO2011063863A2 (de) | Kosmetische oder dermatologische zubereitungen enthaltend kombinationen aus zingeron und grenz- oder oberflächenaktiven polyglycerylverbindungen | |
EP4065239A1 (de) | Wirkstoffkombinationen aus ubichinol und ubichinon, kosmetische oder dermatologische zubereitungen, solche wirkstoffkombinationen enthaltend, und verwendung von ubichinol zur verbesserung der wirksamkeit kosmetischer oder dermatologischer zubereitungen mit einem gehalt an ubichinon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200121 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20201105 |
|
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BEIERSDORF AG |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20220517 |